Trial Design Considerations to Increase Older Adult Accrual to National Cancer Institute Clinical Trials.

MLA

Le-Rademacher, Jennifer, et al. “Trial Design Considerations to Increase Older Adult Accrual to National Cancer Institute Clinical Trials.” Journal of the National Cancer Institute. Monographs, vol. 2022, no. 60, Dec. 2022, pp. 135–41. EBSCOhost, https://doi.org/10.1093/jncimonographs/lgac023.

APA

Le-Rademacher, J., Mohile, S., Unger, J., Hudson, M. F., Foster, J., Lichtman, S., Perlmutter, J., Dotan, E., Extermann, M., Dodd, K., Tew, W., Klepin, H., Wildes, T. M., Sedrak, M. S., Jatoi, A., & Little, R. F. (2022). Trial Design Considerations to Increase Older Adult Accrual to National Cancer Institute Clinical Trials. Journal of the National Cancer Institute. Monographs, 2022(60), 135–141. https://doi.org/10.1093/jncimonographs/lgac023

Chicago

Le-Rademacher, Jennifer, Supriya Mohile, Joseph Unger, Matthew F Hudson, Jared Foster, Stuart Lichtman, Jane Perlmutter, et al. 2022. “Trial Design Considerations to Increase Older Adult Accrual to National Cancer Institute Clinical Trials.” Journal of the National Cancer Institute. Monographs 2022 (60): 135–41. doi:10.1093/jncimonographs/lgac023.